#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese
Why can MS progress even when relapses are controlled? Prof. Manuel Friese explains how complement factor H may help nerve cells resist inflammatory damage, and what still needs to happen before this discovery can become a treatment.
#161: Progressive MS (PMS) – Understanding and Treating PPMS with Dr. Thomas Knoll
This episode explores progressive MS (PMS), including PPMS and SPMS, with neurologist Dr. Thomas Knoll. Learn about disease mechanisms, treatment limits, and how to actively maintain quality of life.
#355: Epigenetische Forschung bei MS. Wie DNA-Methylierung neue Therapieansätze ermöglicht mit Dr. Majid Pahlevan Kakhki
Epigenetische Mechanismen wie die DNA-Methylierung könnten entscheidend dafür sein, wie sich Multiple Sklerose entwickelt. Dr. Majid Pahlevan Kakhki erklärt, wie Umweltfaktoren, Gene und neue Forschung zu personalisierten Therapien beitragen. Ein spannender Einblick in die Zukunft der MS-Behandlung.
#157: The Potential of OCT for Monitoring and Predicting Multiple Sclerosis (with Dr. Joachim Havla)
Optical coherence tomography (OCT) is a quick and non-invasive eye scan that allows researchers to examine the retina in great detail. Because the retina is part of the central nervous system, OCT may help monitor neurodegeneration and disease activity in multiple sclerosis.
In this interview, neurologist Dr. Joachim Havla explains how OCT works, what retinal thinning may reveal about MS progression, and why it is important to distinguish optic neuritis in MS, NMOSD and MOGAD.
This article is the English adaptation of a German MS-Perspektive podcast episode.
#245: Kann Neurodegeneration bei MS durch Modulation von HERV-W behandelt werden? Interview mit Prof. Dr. Patrick Küry
Prof. Patrick Küry spricht über die Behandlung der Neurodegeneration bei MS durch Modulation von HERV-W und Bindung an sein Hüllprotein.
#033: Can neurodegeneration be treated in MS by modulating HERV-W? Interview with Prof. Dr. Patrick Küry
Prof. Patrick Küry talks about treating neurodegeneration in Multiple Sclerosis by modulating HERV-W and binding to its envelope protein.
